American Healthcare REIT, Inc. (AHR) 株式分析

企業概要

American Healthcare REIT, Inc. is a Maryland-based self-managed real estate investment trust that owns and operates a diversified portfolio of clinical healthcare real estate assets. The company focuses on senior housing, skilled nursing facilities, outpatient medical buildings, and other healthcare facilities located across the United States, the United Kingdom, and the Isle of Man. Operating within the Real Estate sector and specifically the REIT - Healthcare Facilities industry, the firm manages properties that generate revenue through long-term leases with healthcare providers and operators. The company's scale is defined by a market capitalization of $9.23B, annual revenue of $2.26B, and an employee count of 121 individuals. These financial figures indicate that the company has established itself as a significant player in the specialized healthcare infrastructure market, commanding a substantial market value relative to its relatively small workforce, which suggests high asset efficiency and operational leverage inherent to the real estate business model.

財務健全性

The company reported revenue of $2.26B over the trailing twelve months, with a net income of $69.81M and an EBITDA of $387.24M. The substantial gap between the revenue figure and the net income reveals a cost structure with significant operating expenses, as the net income represents only approximately 3.1% of total revenue. The firm generated free cash flow of $341.35M, which provides a critical measure of financial flexibility by indicating the cash available for debt servicing, capital expenditures, or special distributions after accounting for cash outflows to support operations. The gross margin stands at 18.3%, reflecting the direct costs of property ownership and leasing relative to total sales. The operating margin is 6.7%, which indicates the profitability after covering all operating expenses excluding interest and taxes, while the profit margin of 3.1% demonstrates the final bottom-line earnings efficiency after all corporate expenses. In terms of liquidity and leverage, the company holds $114.84M in cash against total debt of $1.69B, resulting in a debt-to-equity ratio of 50.20, which characterizes a highly leveraged balance sheet typical for REITs but requiring careful interest rate management. The current ratio is 0.94, indicating that current assets are slightly less than current liabilities, which suggests tight short-term liquidity conditions where the company must rely on operating cash flow to meet obligations. Return on Equity is 2.5% and Return on Assets is 2.1%, metrics that reveal the effectiveness of management in generating returns on the capital invested by shareholders and the total asset base, respectively. These low return percentages relative to the valuation multiples suggest that the equity capital is yielding modest returns compared to the scale of assets under management.

バリュエーション評価

The trailing twelve-month P/E ratio is 116.93, while the forward P/E is 50.28. The significant difference between these two metrics implies that the market expects a substantial improvement in earnings trajectory over the coming year, driving the forward multiple down from the current historical average. The price-to-book ratio is 2.75, which indicates that the market is pricing the company at a premium of 175% over its tangible book value, reflecting intangible assets such as lease value and location quality. The price-to-sales ratio stands at 4.09, and the EV/EBITDA is 28.01; these alternative valuation metrics suggest that investors are willing to pay a high multiple for revenue and cash flow generation despite the high P/E, potentially due to the stability of healthcare leases. The stock's 52-week high is $54.67 and the 52-week low is $26.48. Without a specific current price provided in the facts, the trading range indicates a volatility of over 100% within the last year, with the current price position relative to the range dependent on real-time market data not included in the static facts. The beta value is 1.18, which means the stock is expected to be 18% more volatile than the broader market index, exposing investors to higher systematic risk during market downturns.

Growth & Income

The company experienced revenue growth of 11.9% year-over-year, while earnings growth is listed as N/A in the available data. The absence of reported earnings growth alongside strong revenue growth suggests that either earnings are not growing at the same pace as revenue or that the metric is not yet fully realized in the financial statements. For dividend payers, the company offers a dividend yield of 2.0% with a payout ratio of 238.1%. This payout ratio is unsustainable given the current net income of $69.81M against free cash flow of $341.35M, as the payout exceeds earnings significantly, likely relying on non-cash items or special distributions to maintain the yield. Since the payout ratio exceeds 100%, the company is not retaining earnings for internal growth but is instead distributing a portion of its cash flow that exceeds its reported net income, which could pressure future dividends if earnings do not accelerate. The overall growth and income profile is characterized by strong revenue expansion and a high-yield dividend that currently exceeds the company's reported earnings capacity.